Stock Quote

BioLargo Discusses Ikigai Partnership and PFAS Treatment Technology with The Stock Day Podcast

Phoenix, Arizona--(Newsfile Corp. - October 25, 2021) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), a company that invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, and infection control. President and CEO of BioLargo Dennis P. Calvert, joined Stock Day host Everett Jolly for an interview.

Jolly began by asking about the company's innovative water treatment technology for per- and polyfluoroalkyl substances (PFAS), a class of water contaminants of escalating human health and regulatory concern. Calvert explained that this technology has unprecedented performance compared to existing technologies. "We are at the forefront of presenting a technical innovation that has a chance to be the industry leader," said Calvert. "This is a solution that demands global reach," he added, noting that the company intends on licensing the technology to well-established water treatment distributors and plans to launch the technology in 2022.

Calvert then discussed the company's odor and VOC (volatile organic compound) control solutions, which are at the center of a new consumer product partnership with Ikigai Holdings, LLC. "We're going to keep the market posted as that product goes into test marketing," said Calvert. The company will manufacture the new consumer odor control product (based on an existing BioLargo IP), and Ikigai Holdings will finance and manage its roll-out, distribution, and marketing.

To close the interview, Calvert encouraged listeners and shareholders to check out the company's recent letter to stockholders and keep up-to-date on their current and upcoming projects as they continue to develop and commercialize their solutions.

To hear the entire interview, follow the link to the podcast here: https://audioboom.com/posts/7966717-biolargo-discusses-ikigai-partnership-and-pfas-treatment-technology-with-the-stock-day-podcast.

Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/.

About BioLargo, Inc.

BioLargo, Inc. (OTCQB: BLGO) invents, develops, and commercializes innovative platform technologies to solve challenging environmental problems like PFAS contamination, advanced water and wastewater treatment, industrial odor and VOC control, air quality control, and infection control. With over 13 years of extensive R&D, BioLargo holds a wide array of issued patents, maintains a robust pipeline of products, and provides full-service environmental engineering. Our peer-reviewed scientific approach allows us to invent or acquire novel technologies and develop them to maturity through our operating subsidiaries. With a keen emphasis on collaborations with academic, municipal, and commercial organizations and associations, BioLargo has proven itself with over 80 awarded grants and numerous pilot projects. We monetize through direct sales, recurring service contracts, licensing agreements, strategic joint venture formation and/or the sale of the IP. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

Safe Harbor Act

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company's business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

About The "Stock Day" Podcast

Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America.

SOURCE:
Stock Day Media
(602) 821-1102

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/100720

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.